Analyst Flags Kura Oncology, Inc. (KURA) for 2026 Milestones and Pipeline Expansion

We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. One of the twenty stocks on our list of best biotech stocks is Kura Oncology, Inc. TheFly reported on January 13 that Leerink Partners lowered the price target on KURA to $20 from $25 and maintained an Outperform rating. This revision reflects updates to the model incorporating preliminary Q4 financial results, which include Komzifti’s net product revenue, collaboration revenue, and 2026 guidance ahead of the company’s Q4 earn ...